CLDQ SF-36 | AS | FA | SS | AC | EF | WO | Total |
---|---|---|---|---|---|---|---|
PF | 0.48 | 0.60 | 0.62 | 0.61 | 0.46 | 0.55 | 0.66 |
RP | 0.49 | 0.75 | 0.52 | 0.60 | 0.55 | 0.67 | 0.70 |
BP | 0.73 | 0.72 | 0.81 | 0.71 | 0.53 | 0.57 | 0.80 |
GH | 0.51 | 0.70 | 0.59 | 0.59 | 0.57 | 0.65 | 0.70 |
VT | 0.41 | 0.81 | 0.47 | 0.53 | 0.59 | 0.48 | 0.64 |
SF | 0.45 | 0.69 | 0.42 | 0.57 | 0.72 | 0.64 | 0.67 |
RE | 0.35 | 0.38 | 0.35 | 0.46 | 0.59 | 0.44 | 0.51 |
MH | 0.24 | 0.41 | 0.18 | 0.35 | 0.76 | 0.46 | 0.46 |
PCS | 0.61 | 0.78 | 0.73 | 0.66 | 0.46 | 0.62 | 0.76 |
MCS | 0.38 | 0.54 | 0.28 | 0.44 | 0.82 | 0.48 | 0.56 |
AC, activity; AS, abdominal symptoms; BP, body pain; CLDQ, Chronic Liver Disease Questionnaire; EF, emotional function; FA, fatigue; GH, general health; NASH, non-alcoholic steatohepatitis; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social function; SF-36, Short-Form 36; SS, systemic symptoms; VT, vitality; WO, worry.